Axios @axios
One glaring hole in Democrats' drug pricing outline: It says that drug companies that refuse to negotiate with Medicare will be subject to a tax. But they don't say what that tax will be. If the penalty isn't large enough, drugmakers simply won't comply. https://t.co/tYjqaJ9BpP — PolitiTweet.org
